ICAHRIS
search only ICAHRIS™
Select Language

Management Team

Dr Khadija El Abdaimi, PhD
Dr Gabriel Pulido-Cejudo
President and Chairman

Dr Gabriel Pulido-Cejudo

Inventor and author, Dr Gabriel Pulido-Cejudo is President and Chairman at the International Centre for the Advancement of Health Regional Innovation and Science™.
Federico Amezcua
Director, BioConvergene Technologies™

Federico Amezcua

Federico Amezcua commenced his professional career as an accomplished Mexican lawyer.
Dr. Carlos Amezcua
Director, BioConvergene Technologies™

Dr Carlos Amezcua

Dr Carlos Amezcua possesses several degrees and academic training from a variety of Universities.
Peter Humphries
Director, iBioSign Health Integrated Systems™

Peter Humphries

Peter Humphries is the Chief Information Officer (CIO) of iBioSign Health Integrated Systems™.
Andrés Pulido Esteva
Chief Filmmaker and Videographer

Andrés Pulido Esteva

As Chief Filmmaker and Videographer at ICAHRIS™, Andrés is responsible for our promotional and documentary videos.
Mary Stier-Meyer
Advisory Board Member

Mary Stier-Meyer

Mary, a successful and vibrant entrepreneur, has joined the advisory board of ICAHRIS™.
Sara Ravelo
Advisory Board Member

Sara Ravelo

Sara, a young, prominent musician, has joined the advisory board of ICAHRIS™.
Oksana Pavlova
Advisory Board Member

Oksana Pavlova

Oksana, a vibrant Ukrainian pianist, has joined the advisory board of ICAHRIS™.
Mónica Muraira
Advisory Board Member

Mónica Muraira

Mónica, a successful media host, has joined the advisory board of ICAHRIS™.
Richard A. Patten
Former Director, BioConvergene Technologies™

Richard A. Patten

Richard A. Patten had a vast experience in the voluntary and private Sectors.

Dr Khadija El Abdaimi, PhD

Executive Summary

Dr Khadija El Abdaimi, PhD, is a scientist with extensive experience in research and development, both in academic as well as within the Life Sciences and related industry sectors. She received her PhD at Val de Marne University in Paris, France, in 1995. In 1996, she moved to Montreal, Canada, where she completed post-doctoral training at the Calcium Research Laboratory at McGill University.

Relevant scientific contributions of Dr El Abdaimi include, amongst others, the elucidation of potential mechanisms involved in osteolytic metastases associated to breast cancer. In addition, Dr El Abdaimi was one of the original proponents of the therapeutic potential of Vitamin D in reducing the metastatic bone lesions of breast cancer. In 2000, she joined The Canadian Breast Cancer Laboratories as a Research Scientist. Recently, she received a certificate of accomplishment in clinical trials design and interpretation at Johns Hopkins University (USA). Dr El Abdaimi is currently a clinical trials professional at University of Texas Southwestern Medical Center.